| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,712 | 60,790 | 72,086 | 92,264 | | Cost of Revenue | (15,561) | 39,986 | 40,769 | 61,216 | | | Gross Profit | 18,273 | 20,804 | 31,317 | 31,048 | | | Operating Expenses | | Research Development | 417 | 1,619 | 1,881 | 2,060 | | Selling General and Administrative | 5,721 | 28,809 | 37,259 | 32,585 | | Non Recurring | 559 | 11,767 | 3,821 | 43,741 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 11,576 | (21,391) | (11,644) | (47,338) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 863 | (89) | (283) | (3,578) | | Earnings Before Interest And Taxes | 12,439 | (21,480) | (11,927) | (50,916) | | Interest Expense | 4 | 1 | 147 | 254 | | Income Before Tax | 12,435 | (21,481) | (12,074) | (51,170) | | Income Tax Expense | (530) | (710) | 1,745 | (9,946) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 12,965 | (20,771) | (13,819) | (41,224) | | | Non-recurring Events | | Discontinued Operations | (37,383) |
-
|
-
| (10) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (24,418) | (20,771) | (13,819) | (41,234) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($24,418) | ($20,771) | ($13,819) | ($41,234) |
|
0.15% Nasdaq 
Income Statement
